BiomX To Present Pre-clinical Data at the Plenary Session of the AACR Microbiome, Viruses, and Cancer Conference
BiomX Inc. COmmon Stock (PHGE)
Company Research
Source: Business Wire
NESS ZIONA, Israel--(BUSINESS WIRE)--BiomX, a microbiome company developing both natural and engineered phage therapies, today announced that the company will present pre-clinical data from its colorectal cancer program at the plenary session of the American Association for Cancer Research (AACR) Microbiome, Viruses, and Cancer Conference taking place from February 21-24, 2020, in Orlando, Florida. BiomX’s colorectal cancer program utilizes phage to target bacteria that are naturally present within tumors, with the aim of converting ‘cold’ tumors to ‘hot’ by delivering a payload (i.e. an immunostimulatory payload) to the tumor and eradicating tumor-protective bacteria.Details of the presentation are as follows:Abstract Title: “Novel Phages Targeting The Intratumor Associated Bacteria Fusobacterium Nucleatum”Date: Sunday, February 23, 2020Time: 10:15 a.m. – 12:15 p.m. ETPlenary Session 5: Oncogenic Viruses, Part 2Poster Number: B20About Phage TherapyBacteriophage, or phage, are vir
Show less
Read more
Impact Snapshot
Event Time:
PHGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PHGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PHGE alerts
High impacting BiomX Inc. COmmon Stock news events
Weekly update
A roundup of the hottest topics
PHGE
News
- Microbiome Sequencing Services Business Report 2024-2030: Strong Investment in Genomics Research Crucial for Market Growth [Yahoo! Finance]Yahoo! Finance
- Converge Bio raises $5.5M Seed to speed up drug discovery and development with Generative AI [Yahoo! Finance]Yahoo! Finance
- BiomX Inc (PHGE) Q3 2024 Earnings Call Highlights: Strong Net Income Amid Rising Expenses [Yahoo! Finance]Yahoo! Finance
- BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program Updates [Yahoo! Finance]Yahoo! Finance
- BiomX Announces Third Quarter 2024 Financial Results and Provides Business and Program UpdatesGlobeNewswire
PHGE
Earnings
- 11/14/24 - Beat
PHGE
Sec Filings
- 11/14/24 - Form 10-Q
- 11/14/24 - Form 8-K
- 11/13/24 - Form SCHEDULE
- PHGE's page on the SEC website